Cost-utility analysis and eligibility of dapagliflozin for patients with heart failure across the whole spectrum of ejection fraction
20 May 2023 (08:00 - 20:00)
Organised by: 
About the speaker
Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul (Korea (Republic of))
5 More presentations in this session
Assistant Professor N. Bomer (Groningen, NL)
Doctor R. Rascon Sabido (Veracruz, MX)
Doctor M. Amiguet Comins (Castellon de la Plana, ES)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
